Board of Sanofi India approves slump sale of manufacturing facility at Ankleshwar

At meeting held on 10 September 2019

The Board of Directors of Sanofi India at its meeting held on 10 September 2019 approved a transaction for the slump sale and transfer of the manufacturing facility of the Company at Ankleshwar, Gujarat to Zentiva for a consideration of Rs. 261.7 crore, subject to customary working capital adjustments. This transaction is subject to approval of the members, which will be initiated by the Company through a postal ballot process and few other conditions as defined under the Business Transfer Agreement.

Powered by Capital Market - Live News